Welcome to our dedicated page for National Healthcare Properties SEC filings (Ticker: NHPBP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The NHPBP SEC filings page focuses on regulatory documents for National Healthcare Properties, Inc. 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock and its issuer, National Healthcare Properties, Inc. As a Maryland-incorporated real estate investment trust, NHP files periodic and current reports with the U.S. Securities and Exchange Commission that describe its healthcare real estate operations, capital structure and governance. These filings cover the REIT’s seniors housing and outpatient medical facility portfolio, organized into Senior Housing Operating Property (SHOP) and Outpatient Medical Facility (OMF) segments.
Key filings include Form 10-K annual reports and Form 10-Q quarterly reports, which provide audited and interim financial statements, segment information, risk factors and detailed discussions of non-GAAP measures such as Funds from Operations (FFO), Adjusted Funds from Operations (AFFO), NOI, Cash NOI and Adjusted EBITDA. These documents help investors understand how NHP evaluates the performance of its healthcare real estate portfolio and supports obligations on its preferred stock, including NHPBP.
Form 8-K current reports are particularly relevant for NHPBP holders. Recent 8-Ks describe material events such as the entry into a senior unsecured credit agreement, amendments to a rights agreement, board declassification actions, bylaw amendments addressing universal proxy rules and proxy access, and the appointment of key executives and independent directors. These filings also document the declaration of dividends on the 7.125% Series B preferred stock and other preferred series.
On Stock Titan, SEC filings for NHP and NHPBP are updated from the EDGAR system and paired with AI-powered summaries that highlight the most important points, such as changes in leverage, new financing arrangements, governance modifications and preferred stock terms. Users can also review equity-related filings, including descriptions of the 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, along with any future Forms 4 that may report insider transactions in the company’s securities.
National Healthcare Properties, Inc. reported a narrower quarterly loss while continuing to streamline its balance sheet. For Q3, revenue from tenants was $86.0 million versus $88.9 million a year ago, and net loss attributable to common stockholders was $15.9 million (basic and diluted EPS $(0.56)), improving from $44.1 million last year. Year to date, revenue from tenants was $257.8 million, with a net loss attributable to common stockholders of $45.1 million.
Total assets were $1.74 billion, down from $1.95 billion at year-end, reflecting property sales and lower real estate balances. Net real estate investments declined to $1.54 billion. Debt balances included mortgage notes payable, net of $696.8 million, and Fannie Mae secured debt of $336.2 million. Operating expenses benefited from the absence of related-party operating and termination fees seen in 2024, partially offset by $6.6 million of Q3 impairment charges. The company recorded a Q3 gain on sale of real estate of $0.6 million and year-to-date gains of $28.3 million.
Cash from operations was a modest use of $3.0 million year to date, while investing provided $73.1 million (driven by $90.3 million of sale proceeds). Financing used $41.7 million, including debt repayments and preferred stock repurchases. As of October 30, 2025, common shares outstanding were 28,426,694.
National Healthcare Properties, Inc. reported a narrower quarterly loss while continuing to streamline its balance sheet. For Q3, revenue from tenants was $86.0 million versus $88.9 million a year ago, and net loss attributable to common stockholders was $15.9 million (basic and diluted EPS $(0.56)), improving from $44.1 million last year. Year to date, revenue from tenants was $257.8 million, with a net loss attributable to common stockholders of $45.1 million.
Total assets were $1.74 billion, down from $1.95 billion at year-end, reflecting property sales and lower real estate balances. Net real estate investments declined to $1.54 billion. Debt balances included mortgage notes payable, net of $696.8 million, and Fannie Mae secured debt of $336.2 million. Operating expenses benefited from the absence of related-party operating and termination fees seen in 2024, partially offset by $6.6 million of Q3 impairment charges. The company recorded a Q3 gain on sale of real estate of $0.6 million and year-to-date gains of $28.3 million.
Cash from operations was a modest use of $3.0 million year to date, while investing provided $73.1 million (driven by $90.3 million of sale proceeds). Financing used $41.7 million, including debt repayments and preferred stock repurchases. As of October 30, 2025, common shares outstanding were 28,426,694.